RPAM
Rhenman & Partners Asset Management Portfolio holdings
AUM
$791M
1-Year Return
12.81%
This Quarter Return
+14.02%
1 Year Return
+12.81%
3 Year Return
+98.32%
5 Year Return
+175.58%
10 Year Return
+579.5%
AUM
$1.23B
AUM Growth
+$101M
(+9%)
Cap. Flow
-$32.4M
Cap. Flow
% of AUM
-2.65%
Top 10 Holdings %
Top 10 Hldgs %
30.12%
Holding
96
New
14
Increased
27
Reduced
30
Closed
13
Top Buys
| 1 |
AbbVie
ABBV
|
$23.6M |
| 2 |
Teladoc Health
TDOC
|
$23M |
| 3 |
Johnson & Johnson
JNJ
|
$18.1M |
| 4 |
Merck
MRK
|
$15.1M |
| 5 |
Royalty Pharma
RPRX
|
$12.5M |
Top Sells
| 1 |
NovoCure
NVCR
|
$50.1M |
| 2 |
MYOK
MyoKardia, Inc. Common Stock
MYOK
|
$25.9M |
| 3 |
LVGO
Livongo Health, Inc. Common Stock
LVGO
|
$23.4M |
| 4 |
BioMarin Pharmaceuticals
BMRN
|
$20.6M |
| 5 |
IMMU
Immunomedics Inc
IMMU
|
$18.8M |
Sector Composition
| 1 | Healthcare | 97.59% |
| 2 | Industrials | 0.53% |
| 3 | Communication Services | 0% |
| 4 | Consumer Discretionary | 0% |
| 5 | Energy | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Exact Sciences
EXAS
$9.73B
| $9.94M | 0.81% |
75,000
-5,000
| -6% | -$662K |
|
52
Biogen
BIIB
$20.5B
| $9.79M | 0.8% |
40,000
+7,000
| +21% | +$1.71M |
|
53
Glaukos
GKOS
$5.17B
| $9.41M | 0.77% |
125,000
-15,000
| -11% | -$1.13M |
|
|
RDUS
54
DELISTED
Radius Health, Inc.
RDUS
| $8.61M | 0.7% |
481,826
+150,000
| +45% | +$2.68M |
|
|
SILK
55
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $7.87M | 0.64% |
125,000
-15,000
| -11% | -$945K |
|
56
MeiraGTx Holdings
MGTX
$621M
| $6.81M | 0.56% |
450,000
+75,000
| +20% | +$1.14M |
|
57
Adverum Biotechnologies
ADVM
$66.5M
| $6.78M | 0.55% |
62,500
| – | – |
|
|
ACCD
58
DELISTED
Accolade, Inc. Common Stock
ACCD
| $6.53M | 0.53% |
150,000
-1,674
| -1% | -$72.8K |
|
|
RVNC
59
DELISTED
Revance Therapeutics, Inc.
RVNC
| $6.24M | 0.51% |
220,000
| – | – |
|
|
SWAV
60
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $6.22M | 0.51% |
60,000
| – | – |
|
61
Rigel Pharmaceuticals
RIGL
$720M
| $6.08M | 0.5% |
173,618
| – | – |
|
62
Phathom Pharmaceuticals
PHAT
$851M
| $5.81M | 0.47% |
+175,000
| New | +$5.81M |
|
63
Intuitive Surgical
ISRG
$163B
| $5.73M | 0.47% |
21,000
-15,000
| -42% | -$4.09M |
|
64
Agios Pharmaceuticals
AGIO
$2.1B
| $5.63M | 0.46% |
130,000
+40,000
| +44% | +$1.73M |
|
|
MYOV
65
DELISTED
Myovant Sciences Ltd.
MYOV
| $5.52M | 0.45% |
200,000
-180,000
| -47% | -$4.97M |
|
66
FibroGen
FGEN
$45.7M
| $5.38M | 0.44% |
5,800
| – | – |
|
|
ARNA
67
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $5.38M | 0.44% |
70,000
-140,778
| -67% | -$10.8M |
|
|
GTHX
68
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $4.32M | 0.35% |
240,000
+50,000
| +26% | +$900K |
|
|
FPRX
69
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $4.25M | 0.35% |
+250,000
| New | +$4.25M |
|
70
Alkermes
ALKS
$4.77B
| $4.18M | 0.34% |
209,354
-100,646
| -32% | -$2.01M |
|
71
Dynavax Technologies
DVAX
$1.17B
| $4.12M | 0.34% |
925,534
| – | – |
|
|
OSH
72
DELISTED
Oak Street Health, Inc.
OSH
| $3.67M | 0.3% |
+60,000
| New | +$3.67M |
|
|
DCPH
73
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $3.42M | 0.28% |
+60,000
| New | +$3.42M |
|
74
Annexon
ANNX
$236M
| $3.25M | 0.27% |
+130,000
| New | +$3.25M |
|
|
VRAY
75
DELISTED
ViewRay, Inc.
VRAY
| $2.96M | 0.24% |
775,000
| – | – |
|